Starpharma Holdings Limited (SPL.AX)
| Previous close | 1.3500 |
| Open | 1.3400 |
| Bid | 1.3500 x 334700 |
| Ask | 1.4000 x 1317400 |
| Day's range | 1.3250 - 1.3950 |
| 52-week range | 1.0150 - 2.5200 |
| Volume | 540,759 |
| Avg. volume | 538,392 |
| Market cap | 562.418M |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 1988 |
| 1y target est | N/A |
- PR Newswire
VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant
Starpharma today announced new data demonstrating that SPL7013, the antiviral agent in VIRALEZE™ nasal spray, is active against the highly transmissible Delta variant of SARS-CoV-2, achieving more than 99.99% reduction of infectious virus in laboratory-based virucidal assays.
- GlobeNewswire
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentationsNEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the June 24th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations
- GlobeNewswire
Starpharma to Webcast Live at Life Sciences Investor Forum June 24th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comMELBOURNE, Australia, June 24, 2021 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, OTCQX: SPHRY), based in Melbourne, Australia, today announced that Dr. Jackie Fairley, Chief Executive Officer, will present a pre-recorded presentation at LifeSciencesInvestorForum.com on June 24th. DATE: Thursday, June 24th TIME: 2:30 PM ETLINK: https
